Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/19876
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAgnantis, N. J.en
dc.contributor.authorGoussia, A. C.en
dc.contributor.authorStefanou, D.en
dc.date.accessioned2015-11-24T19:03:11Z-
dc.date.available2015-11-24T19:03:11Z-
dc.identifier.issn0258-851X-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/19876-
dc.rightsDefault Licence-
dc.subjectHumansen
dc.subjectNeoplasms/*pathology/*physiopathologyen
dc.subjectPredictive Value of Testsen
dc.subjectPrognosisen
dc.subject*Tumor Markers, Biologicalen
dc.titleTumor markers. An update approach for their prognostic significance. Part Ien
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/14758728-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2003-
heal.abstractIdentification of prognostic tumor markers is a main strategy for planning treatment and predicting outcome of patients with various malignancies. This article reviews a panel of proliferation markers, hormone receptors, oncogene products and apoptosis regulators that have shown potential as prognostic indicators in common human cancers. At present, steroid receptors and the c-erbB-2 gene are the only tissue-based markers accepted in clinical practice, having an established role in breast cancer prognosis. Other markers e.g., the p53 gene, look promising as prognostic factors in different kinds of cancer.en
heal.journalNameIn Vivoen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons